April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Differentiation of Human Müller Stem Cells Towards a Retinal Ganglion Cell Phenotype
Author Affiliations & Notes
  • Silke Becker
    ORBIT, IoO, University College London, London, United Kingdom
  • Shweta Singhal
    ORBIT, IoO, University College London, London, United Kingdom
  • Hari Jayaram
    ORBIT, IoO, University College London, London, United Kingdom
  • Lauren M. James
    ORBIT, IoO, University College London, London, United Kingdom
  • G. Astrid Limb
    ORBIT, IoO, University College London, London, United Kingdom
  • Footnotes
    Commercial Relationships  Silke Becker, None; Shweta Singhal, None; Hari Jayaram, None; Lauren M. James, None; G. Astrid Limb, None
  • Footnotes
    Support  MRC Grant 90465
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2235. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Silke Becker, Shweta Singhal, Hari Jayaram, Lauren M. James, G. Astrid Limb; Differentiation of Human Müller Stem Cells Towards a Retinal Ganglion Cell Phenotype. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2235.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Glaucoma is one of the leading causes of blindness in the developed world, characterized by the loss of retinal ganglion cells (RGC). In patients with end stage glaucoma, one of the strategies to conserve or restore vision is the replacement of damaged RGC. Human Müller stem cells (hMSC) from the adult retina constitute a potential source for RGC replacement. The present study investigated whether Notch-1 inhibition, which has been shown to induce differentiation of hMSC into RGC, increases hMSC expression of functional nicotinic acetylcholine receptors (nAChR), indicative of a ganglion cell phenotype.

Methods: : The hMSC line MIO-M1 was used in the present investigation. Cells were divided into three treatment groups, which received either no treatment (NM) or which were cultured on matrigel-coated surfaces with FGF-2 in the absence (MF) or presence of the Notch inhibitor DAPT (MFD) for 7 days. Total RNA was extracted, reverse transcribed and PCR was performed using specific primers for nAChR alpha subunits 1-4, 6 and 7 and beta-actin. PCR products were analysed by gel electrophoresis and quantified by densitometry. For calcium imaging MIO-M1 cells were grown on LAB-TEK chambered coverglasses, loaded with Fura Red-AM and the intracellular calcium concentration was estimated by fluorescence microscopy.

Results: : Using RT-PCR we showed that RNA expression for alpha4 and alpha6 nAChR subunits was significantly increased by Notch-1 inhibition. In addition RGC committed precursors, but not undifferentiated MIO-M1 cells, responded to stimulation with nicotine with a substantial rise in the intracellular calcium concentration, which was strongly inhibited by the alpha4 beta2 and alpha6 beta2 nicotinic receptor antagonist methyllycaconitine.

Conclusions: : Our findings indicate that differentiation of MIO-M1 cells by Notch-1 inhibition leads to acquisition of a functional RGC phenotype. The present study provides an important insight into the neural progenicity and differentiation of MIO-M1 cells, which may prove to be an important tool for RGC transplantation to repair retinal function.

Keywords: transplantation • ganglion cells • retina: proximal (bipolar, amacrine, and ganglion cells) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×